13F Data
13F filer · CIK 1475373

SECTOR GAMMA AS

OSLO, Q8 · filing since Q2 2013 · last filing Aug 12, 2026
Reported value
$461.0M
+$37.5M vs prior
Positions
40
New / sold out
7 / 9
Added / reduced
19 / 11
Turnover
20.2%
buys $100.3M · sells $89.2M
Top-10 weight
48.4%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewTHERMO FISHER SCIENTIFIC INC+33,584–+$16.8M
NewREGENERON PHARMACEUTICALS+15,780–+$9.8M
AddedIQVIA HLDGS INC+37,714+93.7%+$7.3M
NewASCENDIS PHARMA A/S+21,305–+$5.7M
AddedMEDTRONIC PLC+71,755+25.6%+$5.6M
AddedABBOTT LABS+59,912+68.4%+$5.4M
AddedGE HEALTHCARE TECHNOLOGIES I+81,445+64.4%+$5.2M
NewBOSTON SCIENTIFIC CORP+121,128–+$5.2M
AddedQIAGEN NV+125,269+77.1%+$4.9M
NewTRAVERE THERAPEUTICS INC+80,000–+$4.5M
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outUNITEDHEALTH GROUP INC-36,435-100.0%$-9.9M
ReducedBIOGEN INC-35,933-39.9%$-7.8M
ReducedAMGEN INC-20,874-44.3%$-7.6M
Sold outGILEAD SCIENCES INC-53,247-100.0%$-7.4M
Sold outLANTHEUS HLDGS INC-93,344-100.0%$-7.1M
ReducedBRUKER CORP-101,658-40.0%$-6.1M
ReducedBRISTOL-MYERS SQUIBB CO-101,786-12.3%$-5.9M
ReducedMERCK & CO INC-43,332-16.6%$-5.6M
Sold outASCENDIS PHARMA A/S-21,305-100.0%$-4.9M
ReducedCARDINAL HEALTH INC-14,208-25.9%$-3.4M
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $342.9MQ3 2013: $389.8MQ4 2013: $370.6MQ1 2014: $417.1MQ2 2014: $422.7MQ3 2014: $427.4MQ4 2014: $449.6MQ1 2015: $378.2MQ2 2015: $391.7MQ3 2015: $369.4MQ4 2015: $389.2MQ1 2016: $485.9MQ2 2016: $526.8MQ3 2016: $571.2MQ4 2016: $531.5MQ1 2017: $628.8MQ2 2017: $687.8MQ3 2017: $656.1MQ4 2017: $594.9MQ1 2018: $554.9MQ2 2018: $601.7MQ3 2018: $637.8MQ4 2018: $594.7MQ1 2019: $623.5MQ2 2019: $622.1MQ3 2019: $591.8MQ4 2019: $624.4MQ1 2020: $469.0MQ2 2020: $484.4MQ3 2020: $439.4MQ4 2020: $525.5MQ1 2021: $546.0MQ2 2021: $564.6MQ3 2021: $501.3MQ4 2021: $425.4MQ1 2022: $460.2MQ2 2022: $447.0MQ3 2022: $388.0MQ4 2022: $437.4MQ1 2023: $412.5MQ2 2023: $446.9MQ3 2023: $391.3MQ4 2023: $412.1MQ1 2024: $354.8MQ2 2024: $267.7MQ3 2024: $329.6MQ4 2024: $290.9MQ1 2025: $312.2MQ2 2025: $305.9MQ3 2025: $403.3MQ4 2025: $438.7MQ1 2026: $423.5MQ2 2026: $461.0M
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1BRISTOL-MYERS SQUIBB COCOM726,115$41.8M9.08%
2MERCK & CO INCCOM217,008$27.9M6.05%
3MEDTRONIC PLCSHS352,437$27.6M5.98%
4PFIZER INCCOM1,004,215$24.2M5.25%
5INCYTE CORPCOM170,753$19.4M4.20%
6ELEVANCE HEALTH INC FORMERLYCOM44,499$17.2M3.73%
7BIOMARIN PHARMACEUTICAL INCCOM294,918$16.9M3.66%
8THERMO FISHER SCIENTIFIC INCCOM33,584$16.8M3.65%
9CVSCVS HEALTH CORP155,337$16.1M3.49%
10IQVIA HLDGS INCCOM77,944$15.1M3.27%
30 more rows. Subscribe for $29/month to see every row, download the data and use the API.